Article Details

Jazz Pharma's combination therapy for lung cancer gets US approval | 104.1 WIKY

Retrieved on: 2025-10-02 22:16:37

Tags for this article:

Click the tags to see associated articles and topics

Jazz Pharma's combination therapy for lung cancer gets US approval | 104.1 WIKY. View article details on hiswai:

Excerpt

Shares of the drugmaker were up 1.6% at $139.30 in extended trade. The drug, Zepzelca, in combination with Roche's Tecentriq, is approved for patients ...

Article found on: wiky.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo